BOT ASX Chart
Snapshot
Botanix Pharmaceuticals Limited (BOT) is a dermatology company headquartered in Philadelphia and Phoenix (US). The company has received FDA approval for its lead product, Sofdra, for the treatment of primary axillary hyperhidrosis. Sofdra is the first and only new chemical entity approved by the FDA for this condition, offering a novel solution that combines safety and effectiveness for patients who previously lacked treatment options for this socially challenging medical disorder.
Share Price Activity (ASX)
| Last (Price) | |
| Change | 0.00 (0.00) |
| Bid / Ask | - |
| Volume | |
| Volume (4w avg) | |
| Turnover | |
| Open | |
| Day Range | - |
| VWAP | |
| Prev Close | |
| Last Trade |
Performance
| 1 Week | |
| 1 Month | |
| 2026 YTD | |
| 1 Year | |
| vs Sector (1yr) | -49.16% |
| vs ASX 200 (1yr) | -87.98% |
Announcements
Corporate Overview
Corporate Details
| Head Office | Docklands VIC 3008 |
| Website | www.botanixpharma.com |
| Registry | Automic Group |
| Auditor | BDO Audit Pty Ltd |
| Date Listed | 24 Jan 1985 |
Upcoming Calendar (Forecasted)
| Date | Event |
|---|---|
| 28/08/2026 | Report (Prelim) |
| 28/08/2026 | Report (Annual) |
| 26/02/2027 | Report (Interim) |
| 01/03/2027 | Report (Interim) |
Former Company Names
- Bone Medical Limited (BNE), 06/07/2016
- Aliquot Asset Management Limited (AQT), 21/01/2004
- Revenir Limited (REV), 20/08/2004
- Aerodata Holdings Limited (ADH), 20/08/2001
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
BOT directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of BOT directors.
Shareholder Info
Substantial Shareholders
No Substantial Shareholders for BOT in our database.
Shareholders Buying
12 month transaction history compiled from ASX announcements.
| Date | Name | Bought | Previous % | New % |
|---|---|---|---|---|
| 18-11-25 | Copia Investment Partners Ltd | 20,600,000 | 6.23 | 7.28 |
| 26-09-25 | Copia Investment Partners Ltd | 20,000,000 | 5.21 | 6.23 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
| Date | Name | Sold | Previous % | New % |
|---|---|---|---|---|
| 14-04-26 | Copia Investment Partners Ltd | 135,277,081 | 6.10 | -- |
| 26-03-26 | Copia Investment Partners Ltd | 7,422,919 | 7.28 | 6.10 |
| 12-03-26 | Insignia Financial Ltd | 120,738,145 | 6.13 | -- |
| 10-11-25 | Insignia Financial Ltd | 20,639,292 | 7.17 | 6.13 |
| 29-10-25 | Insignia Financial Ltd | 20,547,622 | 8.29 | 7.17 |
Historical Data
Share Price History
| Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
Historical Data
| Year | Closing Price | Last Trade |
|---|---|---|
| 2025 | $0.32 | 30 June |
| 2024 | $0.345 | 28 June |
| 2023 | $0.13 | 30 June |
| 2022 | $0.057 | 30 June |
| 2021 | $0.08 | 30 June |
| 2020 | $0.039 | 30 June |
| 2019 | $0.18 | 28 June |
| 2018 | $0.11 | 29 June |
| 2017 | $0.043 | 30 June |
| 2016 | $0.008 | 30 June |
| 2015 | $0.009 | 30 June |
| 2014 | $0.018 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.